Background
==========

Congenital heart disease (CHD) is associated with in utero brain dysmaturation and abnormal cerebral vasculature \[[@B1],[@B2]\]. Phase contrast (PC) MRI allows non-invasive quantification of cerebral blood flow (CBF) and, combined with arterial oxygen saturation (SaO~2~) and haemoglobin (Hgb) concentration, can measure cerebral oxygen delivery (CDO~2~). We hypothesized that CDO~2~ would be lower in newborns with CHD than normals.

Methods
=======

We measured CBF and brain volume (BV) in 32 unsedated newborns (21 normals and 11 CHD) as part of an IRB approved study using a 1.5T Siemens Avanto MRI. CBF was measured according to a previously published technique using a single PC acquisition prescribed perpendicular to both internal carotid arteries (ICA) and basilar artery (BA) at the clivus level \[[@B3]\]. We also measured flows in the vertebral arteries (VA), common carotid arteries (CCA) and internal jugular veins (IJV) using a PC acquisition through the neck. Flows were quantified and indexed to BV calculated from a high resolution 3D T2W FSE acquisition. SaO~2~ and Hgb concentrations were measured using conventional blood gases in order to calculate: CDO~2~=SaO~2~×\[Hgb\]×1.36×CBF \[[@B4]\]. We compared net and indexed CBF and CDO~2~ in the two groups with an unpaired *t*-test with Welch\'s correction (Table [1](#T1){ref-type="table"}). An analysis of CHD subgroups was also performed. The relationship between CBF and gestational age (GA) and agreement between BA vs VA flow sum was examined using Pearson\'s R.

###### 

Table of mean values for all parameters measured, listed as mean ± SEM. P-values refer to comparisons of each subject group to the control group. The CHD subgroups are as follows: single ventricle physiology (SV), transposition of the great arteries (TGA), coarctation of the aorta (CoA), cyanotic and non-cyanotic CHD.

                                                                      Net Value                        Indexed to Brain Volume                                                                                             
  -------------------- ------------------- ------------ ------------- -------------- ----------------- ------------------------- -------------------- --------------------- ----------------- ---------------------------- --------------------
  Patient Type         Brain Volume (ml)   SaO~2~ (%)   Hgb (g/dL)    CBF (ml/min)   P-Value for CBF   CDO~2~ (ml~O2~/min)       P-Value for CDO~2~   CBF (ml/min/ml~BV~)   P-Value for CBF   CDO~2~ (ml~O2~/min/ml~BV~)   P-Value for CDO~2~
                                                                                                                                                                                                                           
  Normal (n=21)        395 ± 12            98           15            138 ± 14                         2749 ± 284                                     0.341 ± 0.027                           6.81 ± 0.54                  
                                                                                                                                                                                                                           
  CHD (n=11)           364 ± 14            90 ± 2.9     15.4 ± 0.44   118 ± 10       0.26              2191 ± 159                0.10                 0.321 ± 0.020         0.56              5.99 ± 0.31                  0.19
                                                                                                                                                                                                                           
  SV (n=4)             364 ± 31            85 ± 6.4     15.5 ± 1.1    122 ± 22       0.58              2101 ± 299                0.15                 0.328 ± 0.036         0.78              5.69 ± 0.49                  0.15
                                                                                                                                                                                                                           
  TGA (n=4)            347 ± 13            89 ± 1.5     15.1 ± 0.38   113 ± 13       0.23              2058 ± 199                0.06                 0.329 ± 0.041         0.82              5.97 ± 0.63                  0.34
                                                                                                                                                                                                                           
  CoA (n=3)            385 ± 28            99 ± 0.67    15.8 ± 0.73   117 ± 20       0.46              2487 ± 382                0.61                 0.301 ± 0.032         0.38              6.40 ± 0.59                  0.63
                                                                                                                                                                                                                           
  Cyanotic (n=7)       365 ± 14            85 ± 2.9     15.7 ± 0.46   124 ± 12       0.47              2198 ± 135                0.09                 0.339 ± 0.027         0.96              6.04 ± 0.36                  0.24
                                                                                                                                                                                                                           
  Non-Cyanotic (n=4)   361 ± 31            100 ± 0.5    15.0 ± 0.98   106 ± 18       0.22              2177 ± 411                0.29                 0.290 ± 0.025         0.19              5.89 ± 0.66                  0.31

Results
=======

Subjects were scanned at a mean corrected GA of 40 weeks. MRI was performed prior to cardiac surgery in all CHD subjects. The two groups had no difference in GA (p=0.07). There were trends towards lower mean net and indexed CBF in CHD newborns compared with controls (control net CBF 138±14 vs CHD 118±10 ml/min (p=0.26), control indexed CBF 0.341±0.027 vs CHD 0.321±0.020 ml/min/ml~BV~ (p=0.56)) (Table [1](#T1){ref-type="table"}, Figure [1a,b](#F1){ref-type="fig"}). A similar trend in mean net and indexed CDO~2~ was observed in CHD newborns compared with controls (control net CDO~2~ 2749±284 vs CHD 2191±159 ml~O2~/min (p=0.1), control indexed CDO~2~ 6.81±0.54 vs CHD 5.99±0.31 ml~O2~/min/ml~BV~ (p=0.19)) (Figure [1c,d](#F1){ref-type="fig"}). In keeping with one previous study (3), CBF increased with GA (r=0.7, p=\<0.0001). The VA and BA flows were highly correlated (r=0.8, p=0.0002), indicating good accuracy of the PC assessment of CBF. There were no significant differences in measured parameters between subgroups of CHD.

![CHD vs control comparisons of parameters plotted against corrected gestational age measured in weeks. a) Net cerebral blood flow (ml/min) vs gestational age; b) Indexed cerebral blood flow to pre-operative brain volume (ml/min/ml~BV~) vs gestational age; c) Net cerebral oxygen delivery (ml~O2~/min) vs gestational age; d) Indexed cerebral oxygen delivery to pre-operative brain volume (ml~O2~/min/ml~BV~) vs gestational age. There is a trend in each parameter towards decreased values in CHD subjects compared to control.](1532-429X-17-S1-M9-1){#F1}

Conclusions
===========

Although the differences between CBF and CDO~2~ in this small sample of subjects were not statistically significant, there was a clear trend towards lower values for both parameters in CHD subjects. We propose that with a larger sample size, these differences will be significant, in keeping with a demonstrable relationship between cerebral oxygenation and brain maturation in CHD fetuses and newborns.
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